...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Message: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
I see this PR announcing to Merck and Eli Lilly,... that there is now competition as to who will do a deal first and get their combo treatment to market first.